跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
李 嘉華
教授
,
醫學檢驗暨生物技術學系
合聘教授
,
醫學生物科技博士學位學程
成員
,
臺北醫學大學癌症轉譯研究中心
https://orcid.org/0000-0002-6015-2239
電子郵件
chlee
tmu.edu
tw
h-index
1832
引文
23
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2005
2024
每年研究成果
概覽
指紋
網路
專案
(18)
研究成果
(53)
資料集
(5)
類似的個人檔案
(6)
指紋
查看啟用 Chia-Hwa Lee 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Nicotinic Receptor
85%
Breast Cancer
79%
Malignant Neoplasm
61%
Colon Cancer
40%
Neoplasm
39%
Thyroid Cancer
35%
Carcinogenesis
33%
Metastasis
27%
Carcinogen
25%
Randomized Controlled Trial
23%
Biological Marker
21%
Imatinib
20%
Triple Negative Breast Cancer
19%
Chronic Myeloid Leukemia
19%
Liver Cancer
17%
Molecular Target
17%
Histone Deacetylase 1
15%
Nicotine-Derived Nitrosamine Ketone
15%
Polyphenol
15%
Phloretin
15%
Terbinafine
15%
Epidermal Growth Factor Receptor
15%
Mouse
15%
Normal Human
14%
Cancer Growth
14%
Anaplastic Thyroid Carcinoma
13%
Receptor Subunit
13%
Histone Deacetylase Inhibitor
10%
Histone
10%
Mouse Model
10%
Glucose Transporter 2
10%
Lung Metastasis
10%
Vasculotropin
9%
Caspase 8
9%
Adverse Event
9%
Histone Deacetylase 2
9%
Tumor Growth
9%
4 (Methylnitrosamino) 1 (3 Pyridyl) 1 Butanone
9%
Mitogen Activated Protein Kinase 3
9%
Phosphotransferase
9%
Colorectal Cancer
9%
Estrogen Receptor
9%
Binding Protein
9%
Recurrent Disease
8%
Carcinogenicity
8%
Apple
8%
Cyclin D1
8%
Protein Tyrosine Kinase Inhibitor
8%
Panobinostat
8%
Combination Therapy
8%
Medicine and Dentistry
Breast Cancer
62%
Cancer Cell
45%
Nicotinic Receptor
38%
Malignant Neoplasm
36%
In Vitro
36%
Metastatic Carcinoma
36%
Programmed Cell Death
34%
Carcinogenesis
25%
Tocopherol
23%
Thyroid Cancer
19%
Triple Negative Breast Cancer
19%
Neoplasm
18%
Clustered Regularly Interspaced Short Palindromic Repeat
17%
Epithelial Cell
17%
Cas9
15%
Meta-Analysis
15%
Colon Cancer
15%
HDAC1
15%
Epidermal Growth Factor Receptor
15%
down Regulation
15%
Invasive Carcinoma
15%
Thyroid Gland
13%
Imatinib
13%
Cell Death
12%
Anaplastic Thyroid Carcinoma
12%
Protein Expression
11%
Chronic Myelogenous Leukemia
11%
Receptor Subunit
11%
Histone Deacetylase Inhibitor
10%
Lung Metastasis
10%
Antineoplastic Activity
10%
Alpha Tocopherol
10%
Real-Time Polymerase Chain Reaction
10%
Signal Transduction
10%
K562 Cells
9%
Colon
9%
Histone Deacetylase 2
9%
Cancer
9%
Knock Out
9%
Breast Cancer Cell Line
9%
Receptor Expression
9%
Succinic Acid
9%
Treatment Response
9%
Estrogen Receptor
9%
Cell Migration
9%
Prostate Tissue
9%
Breast Tissue
9%
Liver Tissue
9%
Circulating Tumor Cell
8%
Carcinogenicity
8%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Colon
32%
Nicotinic Acetylcholine Receptor
29%
Gene Expression
22%
Signal Transduction
22%
Carcinogenesis
21%
Myeloid
20%
Mouse
17%
Tocopherol
15%
down Regulation
15%
Protein Expression
14%
Cell Proliferation
14%
RNA Sequencing
13%
Cell Migration
13%
CRISPR/Cas9
12%
Imatinib
12%
Phosphotransferase
12%
Kinase
12%
Animal Model
11%
Caspase 8
11%
Estrogen Receptor
11%
Real-Time Polymerase Chain Reaction
11%
Single-Nucleotide Polymorphism
11%
Mouse Model
11%
K562 Cells
10%
Flow Cytometry
10%
Vitamin E
10%
Heat Shock Protein
10%
Overall Survival
10%
Messenger RNA
9%
Cell Cycle Arrest
9%
Binding Protein
9%
Antineoplastic Activity
9%
In Vivo Study
9%
Cytotoxicity
8%
Smoking
8%
Transcription
8%
Oncogene
7%
Glucose-Regulated Protein
7%
GLUT2
7%
Hepatitis B Virus
7%
Lysyl Oxidase
7%
G1/S Transition
7%
Quantitative Technique
7%
Chromosome 20
7%
HMGA2
7%
Membrane Protein
7%
Tumor-Related Gene
7%
Open Reading Frame
7%
ABL (Gene)
7%
